MODERN VIEW ON THE PROBLEM OF HOUSE DUST MITES SENSITIZATION



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Dermatophagoides pteronissinus, Dermatophagoides farinea and their products of vital activity are the main allergenic components of house dust. The only pathogenetic and effective method of treatment of patients with house dust mites induced allergic rhinitis and atopic bronchial asthma according to positions of evidencebased medicine is allergenspecific immunotherapy (ASIT) with house dust mites (Dermatophagoides pteronissinus, Dermatophagoides farinea) allergens. Modern data on prevalence of a sensitization to house dust mites at patients with respiratory manifestations of allergy are presented in the review, questions of carrying out ASIT by various methods with application of the standardized allergens, its efficiency and safety are discussed.

Full Text

Restricted Access

About the authors

O M Kurbacheva

Institute of Immunology

Email: Kurbacheva@gmail.com
Moscow, Russia

K S Pavlova

Institute of Immunology

Moscow, Russia

E A Melnikova

A.I. Evdokimov Moscow State Medical and Stomatological University

Moscow, Russia

References

  1. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy (Suppl. 86). 2008, v. 63, p. 1-160.
  2. Matheson M.C., Abramson M.J., Dharmage S.C. et al. Changes in indoor allergen and fungal levels predict changes in asthma activity among young adults. Clin. Exp. Allergy. 2005, v. 35 (7), p. 907-913.
  3. Lau S., Falkenhorst G., Weber A., Werthmann I. et al. High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J. Allergy Clin. Immunol. 1989, v. 84 (5 Pt. 1), p. 718-725.
  4. Sporik R., Holgate S.T., Platts-Mills T.A., Cogswell J.J. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N. Engl. J. Med. 1990, v. 323 (8), p. 502-507.
  5. Kuehr J., Frischer T., Meinert R. et al. Mite allergen exposure is a risk for the incidence of specific sensitization. J. Allergy Clin. Immunol. 1994, v. 94 (1), p. 44-52.
  6. Gregory L.G., Lloyd C.M. Orchestrating house dust mite-associated allergy in the lung. Trends Immunol. 2011, v. 32 (9), p. 402-411.
  7. Fahlbusch B. et al. The effect of storage on allergen and microbial agents levels in frozen house dust. Allergy. 2003, v. 58, p. 150-153.
  8. Da Silva C.A. et al. Chitin particles are multifaceted immune adjuvants. Am. J. Respir. Crit. Care Med. 2010, v. 182, p. 1482-1491.
  9. Pomes A. Allergen structures and biologic functions: the cutting edge of allergy research. Curr. Allergy Asthma Rep. 2008, v. 8, p. 425-432.
  10. Wan H. et al. The transmembrane protein occluding of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin. Exp. Allergy. 2001, v. 31, p. 279-294.
  11. Reed C.E., Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J. Allergy Clin. Immunol. 2004, v. 114, p. 997-1008.
  12. Akers I.A. et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am. J. Physiol Lung Cell Mol. Physiol. 2000, v. 278, L1193.
  13. Hauck R.W. et al. Alpha-Trombin stimulates contractions of human bronchial rings by activation of protease-activated receptors. Am. J. Physiol. 1999, v.277, L222.
  14. Miglino N. et al. House dust mites extract down-regulates C/EBP {alpha} in asthmatic bronchial smooth muscle cells. Eur. Respir. J. 2011, v. 38, p. 50-58.
  15. Siracusa M.C. et al. New paradigms in basophil development, regulation and function. Immunol. Cell Biol. 2010, v. 88, p. 275-284.
  16. Trompette A. et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature. 2009, v. 457, p. 585-588.
  17. Thomas W.R., Smith W. House-dust-mite allergens. Allergy. 1998, v. 53, p. 821-832.
  18. Zhëltikova T.M., Petrova A.D. Nauchnye Doki.The fauna, number and spatial distribution of mites (Acari) in house dust in Moscow. Vyss Shkoly Biol. Nauki. 1990, p. 42-52.
  19. Noguchi E., Shibasaki M. IgE responsiveness to Dermatophagoides farinae in asthma and atopic dermatitis. Int. Arch. Allergy Immunol. 1997, v. 113, p. 489-494.
  20. Didierlaurent A., Garcelon M. Measeurement of IgE specific to a major allergen of house dust mite: Der p 1. J. Immunol. Meth. 1991, v. 145, p. 33-41.
  21. Custovic A., Wijk R.G. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy. 2005, v. 60 (9), p. 1112-1115.
  22. Schmidt L.M., Gotzsche P.C. Of mites and men: reference bias in narrative review articles: a systematic review. J. Fam. Pract. 2005, v. 54 (4), p. 334-338.
  23. Sheikh A., Hurwitz B., Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst. Rev. 2007 (1), CD001563.
  24. Gotzsche P.C., Johansen H.K., Schmidt L.M., Burr M.L. House dust mite control measures for asthma. Cochrane Database Syst. Rev. 2004 (4), CD001187.
  25. Terreehorst I., Hak E., Oosting A.J. et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N. Engl. J. Med. 2003, v. 349 (3), p. 237-246.
  26. Terreehorst I., Duivenvoorden H.J., Tempels-Pavlica Z. et al. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis. Allergy. 2005, v. 60 (7), p. 888-893.
  27. Wood R.A., Johnson E.F., Van-Natta M.L. et al. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am. J. Respir. Crit. Care Med. 1998, v. 158 (1), p. 115-120.
  28. Bjornsdottir U.S., Jakobinudottir S., Runarsdottir V., Juliusson S. The effect of reducing levels of cat allergen (Feld 1) on clinical symptoms in patients with cat allergy. Ann. Allergy Asthma Immunol. 2003, v. 91 (2), p. 189-194.
  29. Global Initiative for Asthma (GINA Report). Global Strategy for Asthma Management and Prevention. Update 2011. http://www.ginasthma.org/uploads/users/files/GINA_Report2011_May4.pdf
  30. Marinho S., Simpson A., Custovic A. Allergen avoidance in the secondary and tertiary prevention of allergic diseases: does it work? Prim. Care Respir. J. 2006, v. 15 (3), p. 152-158.
  31. Bousquet J., Lockey R., Malling H.J. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998, v. 53, suppl. 44, p. 1-42.
  32. Гущин И.С., Курбачева О.М. Аллергия и аллерген-специфическая иммунотерапия. М., «Фармарус Принт Медиа», 2010, 228 с.
  33. Akdis M., Schmidt-Weber C., Jutel M. et al. Mechanisms of allergen immunotherapy. Allergy Clin. Immunol. Int. J. World Allergy Org. 2004, v. 16, No. 2, p. 65-69.
  34. Ozdemir C. An immunological overview of allergen specific immunotherapy - subcutaneous and sublingual routes. Ther. Adv. Resp. Dis. 2009, v. 3 (5), p. 253-262.
  35. Akdis M., Verhagen J., Taylor A. et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T-regulatory 1 and T-helper 2 cells. J. Exp. Med. 2004, v. 199, p. 1567-1575.
  36. Sublingval Immunotherapy: World Allergy Organization Position Paper.
  37. Francis J.N., Till S.J., Durham S.R. Induction of IL-10+ CD4+CD25+ T-cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 2003, v. 11, p. 1255-1261.
  38. Eifan A.O., Calderon M.A., Durham S.R. Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma. Expert. Opin. Biol. Ther. 2013, v. 13 (11), p. 1543-1556.
  39. Radulvic S., Calderon M.A., Wilson D., Durham S. sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst. Rev. 2010, v. 8 (12): CD002893.
  40. Novembre E., Galli E., Landi F. et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 2004, v. 114, p. 851-857.
  41. Pichler C.E., Marquardsen A., Sparholt S. et al. Specific immunotheraoy with Dermatophagoides pteronyssinus and D. farina results in decreased bronchial hyperreactivity. Allergy. 1997, v. 52, p. 274-283.
  42. Zielen S., Kardos P., Madonini E. Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J. Allergy Clin. Immunol. 2010, v. 126 (5), p. 942-949.
  43. Di Rienzo V., Marcucci F., Pucinelli P. et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin. Exp. Allergy. 2003, v. 33 (2), p. 206-210.
  44. Demoly P.M., Bergmann K.C., Melac M. et al. Onset of action of sublingual tablets of house dust mite allergen extracts in adults. J. Allergy Clin. Immunol. 2013, v. 133 (2), Suppl. AB37.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2013



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies